4//SEC Filing
Chadwick Jeremy G 4
Accession 0000950170-24-063947
CIK 0001815442other
Filed
May 22, 8:00 PM ET
Accepted
May 23, 4:10 PM ET
Size
5.3 KB
Accession
0000950170-24-063947
Insider Transaction Report
Form 4
Chadwick Jeremy G
Chief Operating Officer
Transactions
- Sale
Common Stock
2024-05-23$34.99/sh−2,575$90,105→ 44,183 total
Footnotes (2)
- [F1]Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not in the discretion of the reporting person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.65 to $35.2963, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Kymera Therapeutics, Inc.
CIK 0001815442
Entity typeother
Related Parties
1- filerCIK 0001388406
Filing Metadata
- Form type
- 4
- Filed
- May 22, 8:00 PM ET
- Accepted
- May 23, 4:10 PM ET
- Size
- 5.3 KB